Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism - Archive ouverte HAL Access content directly
Journal Articles Blood Year : 2019

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

Lu Wang
  • Function : Author
  • PersonId : 873867
Ben Brumpton
  • Function : Author
Kerri Wiggins
  • Function : Author
James Macdonald
  • Function : Author
Nathan Pankratz
  • Function : Author
Jonas Nielsen
  • Function : Author
Franco Giulianini
  • Function : Author
Marja Puurunen
  • Function : Author
Susan Heckbert
  • Function : Author
Scott Damrauer
  • Function : Author
Pradeep Natarajan
  • Function : Author
Derek Klarin
  • Function : Author
Paul de Vries
  • Function : Author
Maria Sabater-Lleal
  • Function : Author
Jennifer Huffman
  • Function : Author
Theo Bammler
  • Function : Author
Kelly Frazer
  • Function : Author
Bryan Mccauley
  • Function : Author
James Pankow
  • Function : Author
Maiken Gabrielsen
  • Function : Author
Jean-François Deleuze
  • Function : Author
  • PersonId : 1015006
Chris O'Donnell
  • Function : Author
Jihye Kim
  • Function : Author
Barbara Mcknight
  • Function : Author
Peter Kraft
John-Bjarne Hansen
  • Function : Author
Charles Kooperberg
  • Function : Author
Andrew Johnson
  • Function : Author
Nicholas Smith
  • Function : Author

Abstract

Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality. To advance our understanding of the biology contributing to VTE, we conducted a genome-wide association study (GWAS) of VTE and a transcriptome-wide association study (TWAS) based on imputed gene expression from whole blood and liver. We meta-analyzed GWAS data from 18 studies for 30 234 VTE cases and 172 122 controls and assessed the association between 12 923 718 genetic variants and VTE. We generated variant prediction scores of gene expression from whole blood and liver tissue and assessed them for association with VTE. Mendelian randomization analyses were conducted for traits genetically associated with novel VTE loci. We identified 34 independent genetic signals for VTE risk from GWAS meta-analysis, of which 14 are newly reported associations. This included 11 newly associated genetic loci (C1orf198, PLEK, OSMR-AS1, NUGGC/SCARA5, GRK5, MPHOSPH9, ARID4A, PLCG2, SMG6, EIF5A, and STX10) of which 6 replicated, and 3 new independent signals in 3 known genes. Further, TWAS identified 5 additional genetic loci with imputed gene expression levels differing between cases and controls in whole blood (SH2B3, SPSB1, RP11-747H7.3, RP4-737E23.2) and in liver (ERAP1). At some GWAS loci, we found suggestive evidence that the VTE association signal for novel and previously known regions colocalized with expression quantitative trait locus signals. Mendelian randomization analyses suggested that blood traits may contribute to the underlying risk of VTE. To conclude, we identified 16 novel susceptibility loci for VTE; for some loci, the association signals are likely mediated through gene expression of nearby genes.

Dates and versions

hal-02542549 , version 1 (14-04-2020)

Identifiers

Cite

Sara Lindström, Lu Wang, Erin N. Smith, William Gordon, Astrid van Hylckama Vlieg, et al.. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood, 2019, 134 (19), pp.1645-1657. ⟨10.1182/blood.2019000435⟩. ⟨hal-02542549⟩
59 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More